This is the third of three papers that review international policies to control spending on drugs and to improve the efficiency of drug use.
This paper reviews policies regulating the supply of drugs, particularly licensing and reimbursement controls, price and profit regulation.
Price and profit controls contain few incentives for improving cost effective use of drugs, and focus on cost containment and profitability of domestic industry.
Carefully monitored economic evaluation could lead to improvements in efficiency and benefits to patients and the health care system.
Mots-clés Pascal : Contrôle prix, Industrie pharmaceutique, Médicament, Economie santé, Politique sanitaire, Homme
Mots-clés Pascal anglais : Price control, Pharmaceutical industry, Drug, Health economy, Health policy, Human
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 96-0336793
Code Inist : 002B30A08. Création : 10/04/1997.